spacer
home > > winter 2003 > translating the pharma industry
PUBLICATIONS


Translating the Pharma Industry

The value of translations produced in the UK is thought to be worth more than £161 million according to some definitive research carried out last year. This figure may seem relatively low value compared with the market worth of the pharmaceutical sector as a whole, but considering the volume of actual translation jobs needed to produce such a global figure, translation is far from being an insignificant net contributor to UK plc.

Let's get the rest of the statistics out of the way. The translation profession is split into two segments; companies, of which there are around 1,500, and individual freelancers. It is estimated that there are around 8,000 to 9,000 freelance translators, although there are probably more since many individuals who offer translation or interpreting services rarely join one of the recognised professional bodies. The Association of Translation Companies is the only body regulating the company sector of the profession.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Geoffrey Bowden, General Secretary of the Association of Translation Companies

Geoffrey Bowden has been the General Secretary of the Association of Translation Companies for 23 years. In addition to his role with the ATC, he runs a successful PR consultancy, Nexus Structured Communications, specialising in the health sector. The client base of the consultancy includes household names in the pharmaceutical industry.

spacer
Geoffrey Bowden
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

ConsulTech GmbH

ConsulTech GmbH

ConsulTech is a consulting company founded in 1992. Since then, we have been supporting biotech-nology, pharmaceutical and medical technology companies as well as research institutions with the entire process of setting-up and executing proposals for R&D projects. In projects funded by the European Commission, ConsulTech supports the coordinator by resuming administrative tasks allow-ing coordinators and partners to fully concentrate on the scientific and technical success of the pro-ject. We solve financial and administrative issues, organise meetings, take care of the timely delivery of milestones and reports and much more.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement